Drugs that contain Mesalamine
1. Drug name - APRISO
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8865688 | VALEANT PHARMS INTL | Compositions and methods for treatment of bowel diseases with granulated mesalamine |
May, 2030
(7 years from now) | |
Treatment: For the maintenance of remission of ulcerative colitis
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 375MG | CAPSULE, EXTENDED RELEASE;ORAL | Prescription |
2. Drug name - CANASA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8436051 | ALLERGAN | Mesalamine suppository |
Jun, 2028
(5 years from now) | |
| US8217083 | ALLERGAN | Mesalamine suppository |
Jun, 2028
(5 years from now) | |
Treatment: NA
Dosage: SUPPOSITORY;RECTAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 1GM | SUPPOSITORY;RECTAL | Prescription |
| 500MG | SUPPOSITORY;RECTAL | Discontinued |
3. Drug name - ROWASA
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US7645801 | MYLAN SPECIALITY LP | Reduced irritant enema for treatment of inflammatory bowel disease (IBD) |
Jul, 2027
(4 years from now) | |
| EP2107870A4 | MYLAN SPECIALITY LP | Improved Reduced Irritant Enema For The Treatment Of Inflammatory Bowel Disease (Ibd) |
Jan, 2028
(5 years from now) | |
| EP2107870B1 | MYLAN SPECIALITY LP | Reduced Irritant Enema For The Treatment Of Inflammatory Bowel Disease (Ibd) |
Jan, 2028
(5 years from now) | |
| EP2107870A2 | MYLAN SPECIALITY LP | Reduced Irritant Enema For The Treatment Of Inflammatory Bowel Disease (Ibd) |
Jan, 2028
(5 years from now) | |
Treatment: NA
Dosage: ENEMA;RECTAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 4GM/60ML | ENEMA;RECTAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.